comparemela.com

Latest Breaking News On - European scientific working group - Page 5 : comparemela.com

Synairgen PLC presents data on antiviral activity of lead asset

The updates were given to the European Scientific Working Group in Influenza conference

European scientific working group in influenzaEuropean scientific working group

Investegate |Synairgen plc Announcements | Synairgen plc: Data Presented at ESWI Influenza Conference

Investegate announcements from Synairgen plc, Data Presented at ESWI Influenza Conference

United kingdomGeoff nashMary conwayRichard marsdenJohn wardDonna daviesDuncan monteithBrooke clarkeJames blackJessica hodgsonMary jane elliottRatko djukanovicKate bannatyneFreddie barnfieldLucy featherstoneNumis securities limited joint broker

New Data Supports the Effectiveness of Adjuvanted Seasonal Influenza Vaccine in Reducing Influenza-Related Hospitalizations and Healthcare Costs in Older Adults

/PRNewswire/ Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today announced new real-world evidence (RWE).

United kingdomUnited statesNew jerseyMarquez pelaezGregg sylvesterPrnewswire seqirusSergio marquez pelaezItalian journal of public healthCenters for diseaseHealth search databaseGlobal influenza programmeSeqirus united states incWorld health organizationUnited nationsNational institute of statisticsValutazione di health technology assessment

New Data Supports the Effectiveness of Adjuvanted Seasonal Influenza Vaccine in Reducing Influenza-Related Hospitalizations and Healthcare Costs in Older Adults

/PRNewswire/ Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today announced new real-world evidence (RWE).

United kingdomUnited statesNew jerseyMarquez pelaezGregg sylvesterPrnewswire seqirusSergio marquez pelaezItalian journal of public healthCenters for diseaseHealth search databaseGlobal influenza programmeSeqirus united states incWorld health organizationUnited nationsNational institute of statisticsValutazione di health technology assessment

Synairgen Presents In Vitro Potency Data for Interferon Beta Against SARS-CoV-2 Variants and Lung Antiviral Biomarker Data for Inhaled SNG001 at the 8th ESWI Influenza Conference

/PRNewswire/ Synairgen plc (LSE: SNG), the respiratory company developing SNG001, a formulation for inhalation containing the broad-spectrum antiviral.

United kingdomGeoff nashMary conwayRichard marsdenJohn wardDonna daviesDuncan monteithBrooke clarkeJames blackJessica hodgsonMary jane elliottRatko djukanovicKate bannatyneFreddie barnfieldLucy featherstoneNumis securities limited joint broker

vimarsana © 2020. All Rights Reserved.